Braeburn Pharma Announces Publication of Six-Month Bbuprenorphine Implant Data; Clinical Stability Noted (TTNP)
Tweet Send to a Friend
Braeburn Pharmaceuticals announces that the results of the first comparative trial to evaluate efficacy and safety of a six-month buprenorphine ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
